Ubiquitination of Immune System and Cancer Therapy
- PMID: 39546134
- DOI: 10.1007/978-981-97-7288-9_3
Ubiquitination of Immune System and Cancer Therapy
Abstract
Ubiquitination is a post-translational modification mechanism which regulates a variety of signaling pathways and crucial biological processes. It has long been known that ubiquitination regulates the fundamental cellular processes through the induction of proteasomal degradation of target proteins. Meanwhile, the nondegradative types of polyubiquitination modification have been appreciated as important regulatory machinery by modulating the activity or subcellular localization of key signaling proteins. The function of ubiquitination plays an important role in immune responses, which helps to maintain the stability of the internal environment and to control over protein stability and function and are thus critical for the regulation of both innate and adaptive immunity. Furthermore, ubiquitination also regulates both tumor-suppressing and tumor-promoting pathways in cancer. In this review, we will discuss recent progress regarding how ubiquitination regulates immune responses, focusing on Toll-like receptors signaling in innate immunity, T cell activation, TCR signaling, and tumor immunotherapy.
Keywords: Immune response; Immunotherapy; TCR; TLR; Ubiquitination.
© 2024. The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
Similar articles
-
Ubiquitination in the antiviral immune response.Virology. 2015 May;479-480:52-65. doi: 10.1016/j.virol.2015.02.033. Epub 2015 Mar 7. Virology. 2015. PMID: 25753787 Free PMC article. Review.
-
Toll-like receptor regulation of effector T lymphocyte function.Trends Immunol. 2013 Oct;34(10):511-9. doi: 10.1016/j.it.2013.06.003. Epub 2013 Jul 22. Trends Immunol. 2013. PMID: 23886621 Review.
-
The contribution of direct TLR signaling to T cell responses.Immunol Res. 2009;45(1):25-36. doi: 10.1007/s12026-009-8113-x. Immunol Res. 2009. PMID: 19597998 Free PMC article.
-
Regulatory T cells and innate immune regulation in tumor immunity.Springer Semin Immunopathol. 2006 Aug;28(1):17-23. doi: 10.1007/s00281-006-0022-7. Epub 2006 Jul 13. Springer Semin Immunopathol. 2006. PMID: 16838179 Review.
-
Harnessing the Microbiome to Enhance Cancer Immunotherapy.J Immunol Res. 2015;2015:368736. doi: 10.1155/2015/368736. Epub 2015 May 25. J Immunol Res. 2015. PMID: 26101781 Free PMC article. Review.
Cited by
-
SPOP-dependent destabilization of SYT12 in a GSK-3β-dependent manner in papillary thyroid cancer cells.Clin Exp Med. 2025 Jul 10;25(1):243. doi: 10.1007/s10238-025-01791-z. Clin Exp Med. 2025. PMID: 40640517 Free PMC article.
-
The Emerging Role and Mechanism of E2/E3 Hybrid Enzyme UBE2O in Human Diseases.Biomedicines. 2025 Apr 29;13(5):1082. doi: 10.3390/biomedicines13051082. Biomedicines. 2025. PMID: 40426910 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical